Abstract
Preview Management of benign prostatic hyperplasia (BPH) is no longer the cut-and-dried topic that it once was. In this article, Dr Moul presents an update on new medical therapies for mild and moderate cases of BPH and on surgical interventions (some experimental) for more advanced cases. He predicts that intensive research during the next decade will lead to more insight into the most effective therapies for this condition.